Published in J Pediatr on October 01, 1993
Evaluation of Patients With Immune Function Abnormalities | NCT00128973
Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA (2014) 2.89
Evidence of innate lymphoid cell redundancy in humans. Nat Immunol (2016) 2.14
Isolation and characterization of a pigmentless-conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence. Infect Immun (1997) 1.82
Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes. Immunol Res (2011) 1.78
Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years. J Allergy Clin Immunol (2013) 1.66
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol (2013) 1.55
Positive Family History, Infection, Low Absolute Lymphocyte Count (ALC), and Absent Thymic Shadow: Diagnostic Clues for All Molecular Forms of Severe Combined Immunodeficiency (SCID). J Allergy Clin Immunol Pract (2015) 1.42
A human severe combined immunodeficiency (SCID) condition with increased sensitivity to ionizing radiations and impaired V(D)J rearrangements defines a new DNA recombination/repair deficiency. J Exp Med (1998) 1.24
Post-transplantation B cell function in different molecular types of SCID. J Clin Immunol (2012) 1.18
Severe combined immunodeficiencies (SCID). Clin Exp Immunol (2000) 1.17
Antifungal prophylaxis during neutropenia and immunodeficiency. Clin Microbiol Rev (1997) 1.16
Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles. Am J Hum Genet (1998) 1.15
Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases. J Infect (2012) 1.06
Wanted, dead or alive: new viral vaccines. Antiviral Res (2009) 1.02
Virulence potential of Ehrlichia chaffeensis strains of distinct genome sequences. Infect Immun (2007) 1.02
Accumulation of amphotericin B in human macrophages enhances activity against Aspergillus fumigatus conidia: quantification of conidial kill at the single-cell level. Antimicrob Agents Chemother (1998) 0.98
Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience. J Clin Immunol (2000) 0.95
Unsuspected Pneumocystis carinii pneumonia at presentation of severe primary immunodeficiency. Arch Dis Child (2000) 0.94
Immunity to microbes: lessons from primary immunodeficiencies. Infect Immun (2007) 0.93
History and current status of newborn screening for severe combined immunodeficiency. Semin Perinatol (2015) 0.89
Diagnosis of severe combined immunodeficiency. J Clin Pathol (2001) 0.89
Genome wide association study of SNP-, gene-, and pathway-based approaches to identify genes influencing susceptibility to Staphylococcus aureus infections. Front Genet (2014) 0.89
Maternal mosaicism for a novel interleukin-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency in a Navajo kindred. J Clin Immunol (1997) 0.87
Clinical characteristics and genetic profiles of 44 patients with severe combined immunodeficiency (SCID): report from Shanghai, China (2004-2011). J Clin Immunol (2012) 0.85
Human lymphoid development in the absence of common γ-chain receptor signaling. J Immunol (2014) 0.80
Two mutational hotspots in the interleukin-2 receptor gamma chain gene causing human X-linked severe combined immunodeficiency. Am J Hum Genet (1995) 0.80
Virus infections in primary immunodeficiency. J Clin Pathol (1994) 0.80
Severe combined immunodeficiency (SCID) in Canadian children: a national surveillance study. J Clin Immunol (2013) 0.79
Screening for severe combined immunodeficiency in neonates. Clin Epidemiol (2013) 0.79
Generation and maintenance of Listeria-specific CD8+ T cell responses in perforin-deficient mice chronically infected with LCMV. Virology (2007) 0.79
Inborn errors of the development of human natural killer cells. Curr Opin Allergy Clin Immunol (2013) 0.79
Combined immunodeficiency evolving into predominant CD4+ lymphopenia caused by somatic chimerism in JAK3. J Clin Immunol (2014) 0.79
Inborn errors of purine metabolism: clinical update and therapies. J Inherit Metab Dis (2014) 0.78
Transplacental maternal engraftment and posttransplantation graft-versus-host disease in children with severe combined immunodeficiency. J Allergy Clin Immunol (2016) 0.77
Severe combined immunodeficiency in Greek children over a 20-year period: rarity of γc-chain deficiency (X-linked) type. J Clin Immunol (2011) 0.77
Severe combined immunodeficiency in Serbia and Montenegro between years 1986 and 2010: a single-center experience. J Clin Immunol (2014) 0.77
Severe combined immunodeficiency (SCID) associated neutropenia: a lesson from monozygotic twins. Arch Dis Child (1996) 0.75
X-linked severe combined immunodeficiency syndrome: the first Korean case with gamma c chain gene mutation and subsequent genetic counseling. J Korean Med Sci (2004) 0.75
Pathogen-sensing and regulatory T cells: integrated regulators of immune responses. Cancer Immunol Res (2014) 0.75
X-linked severe combined immunodeficiency disease and the gamma c receptor component: prospects for molecular diagnosis. Clin Diagn Lab Immunol (1995) 0.75
Combined immunodeficiencies: twenty years experience from a single center in Turkey. Cent Eur J Immunol (2016) 0.75
Application of Flow Cytometry in the Evaluation of Primary Immunodeficiencies. Indian J Pediatr (2016) 0.75
The benefits and risks of bacille Calmette-Guérin vaccination among infants at high risk for both tuberculosis and severe combined immunodeficiency: assessment by Markov model. BMC Pediatr (2006) 0.75
X-linked severe combined immunodeficiency (X-SCID) with high blood levels of immunoglobulins and Aspergillus pneumonia successfully treated with micafangin followed by unrelated cord blood stem cell transplantation. Eur J Pediatr (2006) 0.75
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science (2003) 19.77
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (1996) 11.13
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science (2000) 10.40
Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science (1984) 10.38
Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell (2000) 9.99
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med (2011) 7.89
Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med (1996) 5.36
Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet (2000) 5.11
Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A (1995) 5.06
Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science (1999) 4.93
Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science (1995) 4.80
Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell (2001) 4.79
The gut-associated lymphoid system: nature and properties of the large dividing cells. Eur J Immunol (1974) 4.76
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science (1998) 4.58
The mouse gut T lymphocyte, a novel type of T cell. Nature, origin, and traffic in mice in normal and graft-versus-host conditions. J Exp Med (1978) 4.57
CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature (1993) 4.11
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86
Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr (1997) 3.63
CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc Natl Acad Sci U S A (2001) 3.54
Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res (1995) 3.33
A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur J Immunol (1987) 3.30
A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet (1999) 3.12
Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell (1988) 3.09
Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome. Lancet (1989) 2.98
The diagnosis and management of chronic cough. Eur Respir J (2004) 2.96
Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat Genet (1997) 2.93
The calcium current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency. J Biol Chem (1994) 2.92
Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci U S A (1995) 2.89
Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest (1997) 2.76
The distribution of large dividing lymph node cells in syngeneic recipient rats after intravenous injection. J Exp Med (1969) 2.76
The Arabidopsis thaliana genome contains at least 29 active genes encoding SET domain proteins that can be assigned to four evolutionarily conserved classes. Nucleic Acids Res (2001) 2.70
The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. The HIV Infection in Newborns French Collaborative Study Group. N Engl J Med (1992) 2.66
Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA (2001) 2.63
A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients. Scand J Rheumatol Suppl (1987) 2.62
Attitudes and knowledge relevant to family planning among New Orleans Negro women. Am J Public Health Nations Health (1966) 2.60
Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest (1990) 2.46
Detection of HIV1 DNA in infants and children by means of the polymerase chain reaction. Lancet (1988) 2.43
Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A (2001) 2.39
Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course. Pediatrics (1994) 2.33
Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS. Lancet (1984) 2.32
Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J Clin Invest (1998) 2.30
Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms. Am J Dis Child (1990) 2.30
CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group. JAMA (1998) 2.25
Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr (1989) 2.22
A syndrome associating partial albinism and immunodeficiency. Am J Med (1978) 2.19
A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature (1985) 2.16
Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia (1996) 2.15
Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study. Pediatrics (1996) 2.14
Patterns of disclosure and perceptions of the human immunodeficiency virus in infected elementary school-age children. Arch Pediatr Adolesc Med (1997) 2.14
Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol (2000) 2.13
PENTA guidelines for the use of antiretroviral therapy, 2004. HIV Med (2004) 2.10
Immunological conditions of children with BCG disseminated infection. Lancet (1995) 2.05
Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med (2001) 2.05
TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol (1999) 2.05
Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis. J Clin Invest (1978) 2.03
Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA (1998) 2.01
Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet (2000) 1.98
Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin Infect Dis (1997) 1.96
Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. Mol Ther (2001) 1.95
Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. JAMA (1996) 1.94
Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur J Immunol (1992) 1.89
Wnt-1 regulation of connexin43 in cardiac myocytes. J Clin Invest (2000) 1.87
Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut (2007) 1.85
Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group. Am J Epidemiol (1995) 1.84